TY - JOUR
AU1 - Wilson, Edward
AU2 - Price, David
AU3 - Musgrave, Stanley
AU4 - Sims, Erika
AU5 - Shepstone, Lee
AU6 - Murdoch, Jamie
AU7 - Mugford, H.
AU8 - Blyth, Annie
AU9 - Juniper, Elizabeth
AU1 - Ayres, Jon
AU1 - Wolfe, Stephanie
AU1 - Freeman, Daryl
AU1 - Gilbert, Richard
AU1 - Hillyer, Elizabeth
AU1 - Harvey, Ian
AB - 
Background: Information is lacking on the relative effectiveness and cost effectiveness — in a real-life primary-care setting — of leukotriene receptor antagonists (LTRAs) and long-acting β2 adrenergic receptor agonists (β2 agonists) as add-on therapy for patients whose asthma symptoms are not controlled on low-dose inhaled corticosteroids (ICS).
TI - Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma
JF - PharmacoEconomics
DO - 10.2165/11537560-000000000-00000
DA - 2012-09-23
UR - https://www.deepdyve.com/lp/springer-journals/cost-effectiveness-of-leukotriene-receptor-antagonists-versus-long-RSqatXSYoJ
SP - 597
EP - 608
VL - 28
IS - 7
DP - DeepDyve
ER -